替罗非班联合双抗治疗对急性脑梗死患者神经功能及血小板功能的影响
DOI:
CSTR:
作者:
作者单位:

台前县新区人民医院

作者简介:

通讯作者:

中图分类号:

基金项目:


Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨替罗非班联合双抗治疗急性脑梗死的临床效果。方法:选取2023年2月至2025年2月期间本院收治的82例急性脑梗死患者作为研究对象。按随机数字表法将研究对象分为对照组(n=41)和观察组(n=41)。对照组采用双抗治疗。观察组采用替罗非班联合双抗治疗。分析比较两组的临床疗效、神经功能[改良爱丁堡-斯堪的纳维亚评分(MESSS)、美国国立卫生研究院卒中量表(NIHSS)]、血栓弹力图指标[血栓最强度(MA)、凝固角(Angle)、凝血反应时间(R)、凝血综合指数(CI)]及不良反应发生率。结果:观察组的治疗总有效率显著高于对照组(P<0.05)。治疗后,两组的MESSS及NIHSS评分均比治疗前显著下降,且观察组治疗后的MESSS及NIHSS评分均较对照组显著降低(P<0.05)。治疗后,两组的MA、Angle、R、CI值均比治疗前显著下降,R值均比治疗前显著提高,且观察组治疗后的MA、Angle值、R、CI值的改善幅度均显著大于对照组(P<0.05)。两组的不良反应发生率无显著差异(P>0.05)。结论:急性脑梗死患者应用替罗非班联合双抗治疗,能够促进神经功能的恢复,抑制血栓形成,提高疗效。

    Abstract:

    Objective: To explore the clinical effect of tirofiban combined with dual antibiotics in the treatment of acute cerebral infarction. Method: 82 patients with acute cerebral infarction admitted to our hospital from February 2023 to February 2025 were selected as the research subjects. The research subjects were divided into the control group (n=41) and the observation group (n=41) according to the random number table method. The control group was treated with double antibiotics. The observation group was treated with tirofiban combined with bispecific antibodies. The clinical efficacy, neurological function [modified Edinburgh Scandinavia Score (MESSS), National Institutes of Health Stroke Scale (NIHSS)], thromboelastography indicators [maximum thrombus strength (MA), Angle of coagulation (Angle), coagulation reaction time (R), comprehensive coagulation index (CI)] and the incidence of adverse reactions of the two groups were analyzed and compared. Result: The total effective rate of treatment in the observation group was significantly higher than that in the control group (P<0.05). After treatment, the MESSS and NIHSS scores of both groups decreased significantly compared with those before treatment, and the MESSS and NIHSS scores of the observation group after treatment were significantly lower than those of the control group (P<0.05). After treatment, the MA, Angle, R and CI values of both groups decreased significantly compared with those before treatment, and the R value increased significantly compared with that before treatment. Moreover, the improvement amplitudes of the MA, Angle, R and CI values in the observation group after treatment were significantly greater than those in the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: The application of tirofiban combined with bispecific antibodies in patients with acute cerebral infarction can promote the recovery of neurological function, inhibit thrombosis, and improve the therapeutic effect.

    参考文献
    相似文献
    引证文献
引用本文

李树新.替罗非班联合双抗治疗对急性脑梗死患者神经功能及血小板功能的影响[J].四川生理科学杂志,2026,48(9):

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-12-11
  • 最后修改日期:2026-01-19
  • 录用日期:2026-01-26
  • 在线发布日期: 2026-08-27
  • 出版日期:
文章二维码